NASDAQ : ACOR

Acorda Therapeutics, Inc.

$0.661 USD

-$0.21 (-24.02%)

Volume
321.67K
Average Volume
139.88K
Market Capitalization
$821.03K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$24.20
Year Low
$0.61
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.33
Company Overview

NASDAQ

Ron Cohen

Drug Manufacturers - Specialty & Generic

Healthcare

ACOR

102

US

USD

https://www.acorda.com

914 347 4300

00484M700

0001008848

Liquidity Metrics

-1.21

0.33

0.26

0.13

0.00

Sales & Valuation

$117.63M

0.01

-0.01

-0.06

-11.47

Profitability

-$203.59

-$252.85M

-214.95%

-251.65%

786.07%

-214.75%

P/E Metrics

0.00

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

19 Analysts

%

Poll Results

About Acorda Therapeutics, Inc. (NASDAQ:ACOR) Stock

Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for ... MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.

Frequently Asked Questions

What is the current Acorda Therapeutics, Inc. (ACOR) stock price?

Acorda Therapeutics, Inc.(NASDAQ:ACOR) stock price is $0.661 in the last trading session. During the trading session, ACOR stock reached the peak price of $24.2 while $0.6116 was the lowest point it dropped to. The percentage change in ACOR stock occurred in the recent session was --24.02% while the dollar amount for the price change in ACOR stock was -$0.21.

ACOR's industry and sector of operation?

The NASDAQ listed ACOR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of ACOR?

Kerry Clem | Chief Commercial Officer
Michael A. Gesser | Chief Financial Officer
Ron Cohen | Founder, Chief Executive Officer, President & Director
Felicia Vonella | Vice President of Investor Relations
Sofia Ali | Senior Vice President of Operations & Strategic Planning

How many employees does ACOR have?

Number of ACOR employees currently stands at 102. ACOR operates from 420 Saw Mill River Road, Ardsley, NY 10502, US.

Link for ACOR official website?

Official Website of ACOR is: https://www.acorda.com

How do I contact ACOR?

ACOR could be contacted at phone #914 347 4300 and can also be accessed through its website. ACOR operates from 420 Saw Mill River Road, Ardsley, NY 10502, US.

How many shares of ACOR are traded daily?

The average number of ACOR shares traded daily for last 3 months was 139.88K.

What is the market cap of ACOR currently?

The market value of ACOR currently stands at $821.03K with its latest stock price at $0.661